| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1551522 | 6480464 | Ethinyl Estradiol results in increased expression of RGS19 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of RGS19 mRNA | CTD | PMID:17351261 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1551522 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGS19 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1353904 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of RGS19 mRNA | CTD | PMID:20404318 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1551522 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RGS19 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1551522 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGS19 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RGS19 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551522 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS19 mRNA | CTD | PMID:17942748 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551522 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS19 mRNA | CTD | PMID:19770486 PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1551522 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RGS19 mRNA | CTD | PMID:17942748 |
| 2-methylcholine | affects expression | ISO | RGD:1353904 | 6480464 | beta-methylcholine affects the expression of RGS19 mRNA | CTD | PMID:21179406 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1551522 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of RGS19 mRNA | CTD | PMID:18648102 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RGS19 mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1551522 | 6480464 | Benzo(a)pyrene results in decreased expression of RGS19 mRNA | CTD | PMID:19770486 |
| chloroprene | decreases expression | ISO | RGD:1551522 | 6480464 | Chloroprene results in decreased expression of RGS19 mRNA | CTD | PMID:23125180 |
| choline | affects expression | ISO | RGD:1353904 | 6480464 | Choline affects the expression of RGS19 mRNA | CTD | PMID:17616785 |
| choline | multiple interactions | ISO | RGD:1551522 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS19 mRNA | CTD | PMID:20938992 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of RGS19 mRNA | CTD | PMID:17602206 |
| copper atom | multiple interactions | ISO | RGD:1353904 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RGS19 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1353904 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of RGS19 mRNA | CTD | PMID:20971185 |
| cyclosporin A | decreases expression | ISO | RGD:1353904 | 6480464 | Cyclosporine results in decreased expression of RGS19 mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | decreases expression | ISO | RGD:1551522 | 6480464 | Dibutyl Phthalate results in decreased expression of RGS19 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:1551522 | 6480464 | Dibutyl Phthalate results in decreased expression of RGS19 mRNA | CTD | PMID:17361019 PMID:21266533 |
| folic acid | multiple interactions | ISO | RGD:1551522 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS19 mRNA | CTD | PMID:20938992 |
| ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of RGS19 mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | ISO | RGD:1551522 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of RGS19 mRNA | CTD | PMID:20938992 |
| lead diacetate | decreases expression | ISO | RGD:1551522 | 6480464 | lead acetate results in decreased expression of RGS19 mRNA | CTD | PMID:21829687 |
| pirinixic acid | decreases expression | ISO | RGD:1551522 | 6480464 | pirinixic acid results in decreased expression of RGS19 mRNA | CTD | PMID:18445702 |
| quercetin | increases expression | ISO | RGD:1353904 | 6480464 | Quercetin results in increased expression of RGS19 mRNA | CTD | PMID:21632981 |
| valproic acid | decreases expression | ISO | RGD:1551522 | 6480464 | Valproic Acid results in decreased expression of RGS19 mRNA | CTD | PMID:21427059 |
| valproic acid | decreases expression | ISO | RGD:1551522 | 6480464 | Valproic Acid results in decreased expression of RGS19 mRNA | CTD | PMID:20546886 PMID:21427059 |
| valproic acid | decreases expression | ISO | RGD:1551522 | 6480464 | Valproic Acid results in decreased expression of RGS19 mRNA | CTD | PMID:21427059 PMID:20546886 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of RGS19 mRNA | CTD | PMID:17074742 |
| zinc sulfate | decreases expression | EXP | | 6480464 | Zinc Sulfate results in decreased expression of RGS19 mRNA | CTD | PMID:17074742 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc results in decreased expression of RGS19 mRNA | CTD | PMID:17074742 |